Retagliptin phosphate - ≥99% , CAS No.1256756-88-3
Auf Lager
SKU
R647061
Retagliptin phosphate (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin phosphate can be used for type 2 diabetes mellitus (T2DM) research
In Vitro
Retagliptin is a class of compound used for research of type 2 diabetes. Retagliptin inhibits the degradation of GLP-1, thus amplifying the incretin effect. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:DPP-4
Weitere Informationen
| CAS | 1256756-88-3 |
|---|---|
| Spezifikationen & Reinheit | ≥99% |
| Storage | Store at 2-8°C,Desiccated |
| Verschickt in | Wet ice |
| Product Description | Retagliptin phosphate (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin phosphate can be used for type 2 diabetes mellitus (T2DM) research In Vitro Retagliptin is a class of compound used for research of type 2 diabetes. Retagliptin inhibits the degradation of GLP-1, thus amplifying the incretin effect. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:DPP-4 |
| Löslichkeit | DMSO : ≥ 150 mg/mL (266.73 mM) |
| PubChem CID | 49820554 |
| Molekulare Formel | C19H21F6N4O7P |
Bewertungen
Kundenbewertungen
Remind me later